Resmed (RMD) Restructuring Costs (2015 - 2025)

Resmed (RMD) posted Restructuring Costs of $5.9 million for Q4 2025, down 62.44% on a QoQ basis from $15.8 million in Q3 2025.

Resmed (RMD) Restructuring Costs (2015 - 2025) Analysis & Trends

Resmed's Restructuring Costs history runs 10 years deep, the most recent figure standing at $5.9 million for Q4 2025.

  • Quarterly Restructuring Costs changed N/A year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $21.7 million (changed N/A YoY) and the FY2024 annual result came in at $64.2 million, up 598.13% from the prior year.
  • Restructuring Costs was $5.9 million for Q4 2025 at Resmed, down from $15.8 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $15.8 million in Q3 2025 and bottomed at -$8.7 million in Q2 2021.
  • A 4-year average of $4.3 million and a median of $5.9 million in 2025 frame the typical range for Restructuring Costs.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.94 Mn
Sep 30, 2025 15.80 Mn
Jun 30, 2023 43,000.00
Dec 31, 2022 8.41 Mn
Jun 30, 2021 -8.67 Mn
Dec 31, 2020 8.67 Mn
Dec 31, 2019 -600,000.00
Jun 30, 2019 35.08 Mn
Dec 31, 2018 6.12 Mn
Jun 30, 2018 7.00 Mn
Mar 31, 2018 10.92 Mn
Mar 31, 2017 7.95 Mn
Dec 31, 2016 8.50 Mn
Dec 31, 2015 6.91 Mn